Uncategorized

Chai tees up Bristol Myers Squibb AI antibody discovery collab

Published

on

A month after Chai Discovery tied up a major $400 million series C funding round, the AI drug discovery firm has teamed up with Bristol Myers Squibb.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version